California Public Employees Retirement System Rocket Pharmaceuticals, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$39.41 - $47.25 $2.52 Million - $3.03 Million	-64,028 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$43.34 - $65.91 $554,708 - $843,582	-12,799 Reduced 16.66%	64,028 $2.84 Million
Q4 2020 Feb 02, 2021	SELL	$23.3 - $59.57 $32,620 - $83,398	-1,400 Reduced 1.79%	76,827 $4.21 Million
Q3 2020 Nov 05, 2020	BUY	$20.5 - $28.59 $59,306 - $82,710	2,893 Added 3.84%	78,227 $1.79 Million
Q2 2020 Aug 12, 2020	BUY	$13.32 - $22.61 $101,125 - $171,655	7,592 Added 11.21%	75,334 $1.58 Million
Q1 2020 May 12, 2020	BUY	$9.71 - $25.11 $182,955 - $473,122	18,842 Added 38.53%	67,742 $945,000
Q4 2019 Jan 27, 2020	BUY	$11.07 - $24.23 $382,069 - $836,274	34,514 Added 239.91%	48,900 $1.11 Million
Q3 2019 Oct 31, 2019	BUY	$10.85 - $14.78 $156,088 - $212,625	14,386 New	14,386 $168,000
Q1 2019 May 03, 2019	SELL	$13.45 - $19.01 $359,814 - $508,555	-26,752 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$18.5 - $25.49 $494,912 - $681,908	26,752 New	26,752 $659,000

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

Rtw Investments, LP New York, NY

17.7M
Shares

$250 Million
5.21% of portfolio
Wellington Management Group LLP Boston, MA

11.2M
Shares

$159 Million
0.04% of portfolio
Black Rock Inc. New York, NY

6.19M
Shares

$87.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.54M
Shares

$78.1 Million
0.0% of portfolio
Westfield Capital Management CO LP Boston, MA

4.49M
Shares

$63.4 Million
0.39% of portfolio

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account